Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis

Can Xu; Heng Li; Chao-Ke Tang

doi:10.1016/j.gendis.2021.12.007

您当前的位置：

首页 >

文章列表页 >

Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis

Review article | 更新时间：2023-05-16

- Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis
- Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis
- Genes & Diseases 2023年10卷第2期
- 作者机构：
  
  Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, The First Affiliated Hospital of University of South China, Department of Cardiology, Hengyang Medical School, University of South China,Hunan,Hengyang,China,421001
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2021.12.007
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-3-1，
扫描看全文
Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis[J]. Genes & Diseases, 2023,10(2).

Can Xu, Heng Li, Chao-Ke Tang. Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis[J]. Genes & Diseases, 2023,10(2).
Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.gendis.2021.12.007.

Can Xu, Heng Li, Chao-Ke Tang. Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.gendis.2021.12.007.

摘要

Abstract

herosclerosis

the underlying pathophysiological basis of cardiovascular disease

has been recognized as a lipid-driven chronic inflammatory disease. Sterol carrier protein 2 (SCP-2) is a 13-kDa non-specific lipid-transfer protein expressed by various tissues and cells

such as liver

heart

vascular smooth muscle cells (VSMCs)

and macrophages. SCP-2 has an extensive role in cardiovascular and metabolic diseases. Recently

SCP-2 was reported to promote the development of atherosclerosis by regulating lipid metabolism and peroxidation

endocannabinoid metabolism

vascular inflammation

and fatty acid metabolism. In this review

we summarized the recent advances regarding the role of SCP-2 in the pathogenesis of atherosclerosis and tried to provide a rationale for future investigation and a better understanding of the biological functions of SCP-2 in atherosclerotic cardiovascular disease.

关键词

Keywords

AtherosclerosisFatty acid metabolismLipid metabolismSCP-2Vascular inflammation

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Recent advances of mechanosensitive genes in vascular endothelial cells for the formation and treatment of atherosclerosis

Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network

Mitochondria-related signaling pathways involved in breast cancer regulate ferroptosis

The Janus-faced role of Piezo1 in cardiovascular health under mechanical stimulation

New insights into the suppression of inflammation and lipid accumulation by JAZF1